Skip to content
Tenfell
Awarded contract
Published 09 Apr 2018

Proprietary Pharmaceuticals — North of England (Tranche B)

The NHS Commissioning Board (operating under the name of NHS England) · United Kingdom

Key facts

Awarded
02 Feb 2018
Contract starts
01 Mar 2018
Contract ends
29 Feb 2020
Procedure
Open procedure (framework)
Buyer type
Health

Awarded to 30 suppliers

SupplierValue
Takeda UK Limited—
Janssen-Cilag Ltd—
Merck Sharp & Dohme UK Ltd—
Pfizer Ltd—
Teva UK Ltd—
BAYER PUBLIC LIMITED COMPANY—
Napp Pharmaceuticals—
Sandoz Ltd—
Eli Lilly & Company Ltd—
Gedeon Richter UK Ltd—
Gilead Sciences Limited—
Ipsen—
Merck Serono Limited—
Novartis Pharmaceuticals UK Ltd—
Novo Nordisk—
Roche Products Ltd—
UCB Pharma Ltd—
Intrapharm Laboratories Ltd—
Ferring Pharmaceuticals Limited—
Mercury Pharmaceuticals Limited—
Bristol-Myers Squibb Pharmaceuticals Ltd—
ROVI Biotech Ltd—
Biogen Idec Ltd.—
Boehringer Ingelheim—
Astellas Pharma Ltd—
Pharmasure—
Daiichi Sankyo UK Ltd—
Genzyme Therapeutics Ltd—
Aventis Pharma Limited t/a Sanofi—
LEOPHARMA LIMITED—

Categories (CPV)

Similar open tenders

About The NHS Commissioning Board (operating under the name of NHS England)

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on TED archive (UK notices before Brexit) (EU open data (Decision 2011/833/EU)). Always read the original notice before responding.